Ścieżyńska A, Soszyńska M, Komorowski M, et al.
Molecular Analysis of the ABCA4 Gene Mutations in Patients with
Stargardt Disease Using Human Hair Follicles. Int J Mol Sci. 2020;21(10):E3430.
doi:10.3390/ijms21103430 (IF: 4,183)
Rumney RMH, Górecki DC. Knockout and Knock-in Mouse Models to Study Purinergic Signaling.
Methods Mol Biol. 2020;2041:17‐43. doi:10.1007/978-1-4939-9717-6_2
2019
Ścieżyńska A, Komorowski M, Soszyńska M, Malejczyk J. NK Cells as Potential
Targets for Immunotherapy in Endometriosis. J Clin Med. 8(9), doi: 10.3390/jcm8091468,
2019 (IF 5,688)
Ścieżyńska A, Nogowska A, Sikorska M, et al. Isolation and culture
of human primary keratinocytes-a methods review. Exp Dermatol.
2019;28(2):107‐112. doi:10.1111/exd.13860 (IF: 2,868)
Górecki DC. P2X7 purinoceptor as a therapeutic target in muscular dystrophies.
Curr Opin Pharmacol 47:40-45, doi: 10.1016/j.coph.2019.02.003, 2019 (IF 5,203).
Róg J, Oksiejuk A, Gosselin MRF, Brutkowski W, Dymkowska D, Nowak N, Robson S,
Górecki DC, Zabłocki K. Dystrophic mdx mouse myoblasts exhibit elevated
ATP/UTP-evoked metabotropic purinergic responses and alterations in calcium signalling.
Biochim Biophys Acta Mol Basis Dis 1865(6):1138-1151, doi: 10.1016/j.bbadis.2019.01.002,
2019 (IF 4,328).
2018
Young CNJ, Górecki DC. P2RX7 Purinoceptor as a Therapeutic Target-The Second Coming?.
Front Chem. 2018;6:248. Published 2018 Jun 28. doi:10.3389/fchem.2018.00248 (IF: 3,782)